Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Business trends
2.2 Product trends
2.3 Technique trends
2.4 Application trends
2.5 End-user trends
2.6 Regional trends
Chapter 3 PCR Technologies Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Technological advancements
3.3.1.2 Increasing prevalence of infectious diseases and genetic disorders
3.3.1.3 Increasing research and development activities
3.3.2 Industry pitfalls & challenges
3.3.2.1 Dearth of trained experts
3.3.2.2 High cost associated with the digital PCR
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By technique
3.4.3 By application
3.4.4 By end-user
3.5 COVID- 19 impact analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Gap analysis
3.9 Regulatory landscape
3.9.1 U.S.
3.9.2 Europe
3.10 Porter's analysis
3.10.1 Supplier power
3.10.2 Buyer power
3.10.3 Threat of new entrants
3.10.4 Threat of substitutes
3.10.5 Competitive rivalry
3.11 PESTEL Analysis
3.11.1 Political
3.11.2 Economic
3.11.3 Social
3.11.4 Technological
3.11.5 Environmental
3.11.6 Legal
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Strategy dashboard, 2022
Chapter 5 PCR Technologies Market, By Product
5.1 Key segment trends
5.2 Reagents & Consumables
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Instrument
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Software & Services
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Hyphenated Instruments
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 PCR Technologies Market, By Technique
6.1 Key segment trends
6.2 Conventional PCR
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Real-Time PCR
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Digital PCR
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Reverse Transcription PCR
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Hot-start PCR
6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Multiplex PCR
6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 OtherTechniques
6.8.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 PCR Technologies Market, By Application
7.1 Key segment trends
7.2 Gene Expression Analysis
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Genetic Sequencing
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Genotyping
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Nucleic Acid Detection
7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Nucleic Acid Synthesis
7.6.1 Market size, by region, 2018 - 2032 (USD Million)
7.7 Standard Validation/ Verification
7.7.1 Market size, by region, 2018 - 2032 (USD Million)
7.8 Diagnostic Application
7.8.1 Market size, by region, 2018 - 2032 (USD Million)
7.9 Evironmental Application
7.9.1 Market size, by region, 2018 - 2032 (USD Million)
7.10 OtherApplications
7.10.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 PCR Technologies Market, By end-user
8.1 Hospitals & Diagnostic Centers
8.1.1 Market size, by region, 2018 - 2032 (USD Million)
8.2 Healthcare
8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 Research & Academics Institutes
8.3.1 Market size, by region, 2018 - 2032 (USD Million)
8.4 Pharma & Biotech Companies
8.4.1 Market size, by region, 2018 - 2032 (USD Million)
8.5 Applied Industries
8.5.1 Market size, by region, 2018 - 2032 (USD Million)
8.6 OtherEnd-users
8.6.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 PCR Technologies Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific Inc.
10.1.1 Business Overview
10.1.2 Financial Data
10.1.3 Product landscape
10.1.4 Strategic Outlook
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Business Overview
10.2.2 Financial Data
10.2.3 Product Landscape
10.2.4 Strategic Outlook
10.2.5 SWOT Analysis
10.3 Abbott Laboratories
10.3.1 Business Overview
10.3.2 Financial Data
10.3.3 Product Landscape
10.3.4 Strategic Outlook
10.3.5 SWOT Analysis
10.4 Eppendrof AG
10.4.1 Business Overview
10.4.2 Financial Data
10.4.3 Product Landscape
10.4.4 Strategic Outlook
10.4.5 SWOT Analysis
10.5 Sysmex Inostic Inc.
10.5.1 Business Overview
10.5.2 Financial Data
10.5.3 Product Landscape
10.5.4 Strategic Outlook
10.5.5 SWOT Analysis
10.6 QIAGEN
10.6.1 Business Overview
10.6.2 Financial Data
10.6.3 Product Landscape
10.6.4 Strategic Outlook
10.6.5 SWOT Analysis
10.7 Bio-Rad Laboratories, Inc
10.7.1 Business Overview
10.7.2 Financial Data
10.7.3 Product Landscape
10.7.4 Strategic Outlook
10.7.5 SWOT Analysis
10.8 Takara Bio Inc.
10.8.1 Business Overview
10.8.2 Financial Data
10.8.3 Product Landscape
10.8.4 Strategic Outlook
10.8.5 SWOT Analysis
10.9 F. Hoffmann-LA Roche Ltd
10.9.1 Business Overview
10.9.2 Financial Data
10.9.3 Product Landscape
10.9.4 Strategic Outlook
10.9.5 SWOT Analysis
10.10 Merck KGaA
10.10.1 Business Overview
10.10.2 Financial Data
10.10.3 Product Landscape
10.10.4 Strategic Outlook
10.10.5 SWOT Analysis
10.11 Fluidigm Corporation
10.11.1 Business Overview
10.11.2 Financial Data
10.11.3 Product Landscape
10.11.4 Strategic Outlook
10.11.5 SWOT Analysis
10.12 Promega Corporation
10.12.1 Business Overview
10.12.2 Financial Data
10.12.3 Product Landscape
10.12.4 Strategic Outlook
10.12.5 SWOT Analysis
